Overview

Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months

Status:
Completed
Trial end date:
2016-11-30
Target enrollment:
Participant gender:
Summary
The Open-Label Maintenance Study contains an Acute Phase, in which subjects will be dosed with ZS 10 g three times daily (tid) for 24 to 72 hours, followed by a long-term Maintenance Phase.
Phase:
Phase 3
Details
Lead Sponsor:
ZS Pharma, Inc.